ACCL1931, A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy

Phase

Phase III Clinical Trial

Condition(s)

Leukemia

Trial Number

05602194

Trial Status

OPEN